NanoSyrinx have raised £7m in funding to date. We talked to Dr Joe Healy, Co-Founder and CEO at NanoSyrinx Ltd. They are on a mission to fundamentally revolutionise how medicines are administered - on a nanoscopic scale. We focused on how the ICURe programme helped validate the business. ICURe (Innovation to Commercialisation of University Research)…
WID Case Study: NanoSyrinx – Delivering the future of intracellular medicine
